Selective Guanylyl Cyclase Inhibitor Reverses
Nitric Oxide-Induced Vasorelaxation Linda J. Olson, Edward T Knych Jr, Thomas C Herzig, James G Drewett Abstract Effects of a novel soluble guanylyl cyclase mhtbrtor, lH-[1,2,4]oxadtazolo [4,3-a] qumoxal~n-l-one (ODQ), were characterized on guanylyl cyclase activity m cytosohc fraction of COS-7 cells overexpressmg the (Y, and PI subunits of the rat soluble enzyme ODQ was a noncompetmve mhtbttor of soluble guanylyl cyclase with respect to Mn'+ or Mn'+-GTP and was a mixed competrttve/noncompetltlve mhrbltor wtth respect to mtnc oxide (NO) donation ODQ (10 pmol/L) reduced deta nonoatestimulated cGMP productron m COS-7 cells overexpressmg soluble guanylyl cyclase and m rat aorttc vascular smooth muscle cells ODQ did not mhrbtt parttculate forms of the enzyme rat guanylyl cyclase-A, -B, or -C, did not block NO synthase, and did not auto-oxrdtze deta nonoate-donated NO m the presence of cells at physrologrcal pH Therefore, ODQ IS a selective mhrbttor of soluble guanylyl cyclase Using ODQ m isolated aorttc rmg preparations, we tested the hypothesis that soluble guanylyl cyclase mediates vasorelaxant acttvtty associated with NO Phenylephrme (100 nmol/L)-precontracted, isolated rat aortas were relaxed m a concentratton-dependent manner by deta nonoate (001 to 100 pmol/L) and mtroglycerm (001 to 300 hmol/L) ODQ (10 pmol/L) attenuated deta nonoate-and mtroglycermmediated relaxatron of contracted aortas ODQ had no effect on natrmrettc peptrde-, S-bromo-cGMP-, rsoproterenol-, or brmakahm-mediated aorttc relaxation These results support the hypothesis that soluble guanylyl cyclase mediates vasorelaxant acttvtty associated with mtnc oxide (Hypertension. 1997; 29 [part 2]:254-261.) Key Words l cychc GMP l endothelmm-dertved relaxing factor l guanylyl cyclase l mtrtc oxide l mtrtc oxtde synthase l natrmrettc peptrdes l vasodrlatatton N 'itrtc oxide is now known to be the maJor endothehum-dertved relaxmg factor I* Several vasodilators, mcludmg bradykmm, acetylcholme, and serotonm, are thought to have activity by virtue of then effects to strmulate endothelial cell NOS. 12 Several studies over the years have suggested that the vasodilatory actions of NO are mediated by increases m cGMP'-3 NO and several precursors of the radical activated soluble forms of guanylyl cyclase,l-4 and membrane permeable analogs of cGMP vasodilated blood vessels 1 5 In addltron, m most studies NO-stimulated production of cGMP correlates with the NO-mediated vasodilation However, NO-induced smooth muscle relaxation has been drssociated from increases m cGMP in some studies.4.6.7 Potential explanations for the latter observation are that NO also stimulates guanylyl cyclase activity in cell types other than vascular smooth muscle (ie, adventrtia, fibroblasts, autonomic nerves, and/or endothelmm), that current assays for vascular contractile responses are significantly more sensitive than the measurement of cGMP concentrations wnhm cellular compartments associated with vasoactivny, and that NO may mediate vascular effects independent of guanylyl cyclase stimulation Several groups have used either methylene blue or LY83583 as sGC mhibitors to focus on the latter posabihty by attempting to dissociate NO-mediated smooth muscle relaxation from increases in enzyme activatton 1,~ Both of these compounds appear to block the From donors, including mtroglycerm, sodium mtroprusstde, and 3-morpholmo-sydnommme (ie, SIN-l) Therefore, methylene blue and LY83583 have been used to reach the concluston that sGC mediates the vasodllatory effect of NO. This concluston IS questionable because both methylene blue and LY83583 are not truly selective sGC mhibitors, and then effects on the NO/sGC system are likely completely or partially explained by mdnect actions Methylene blue is now known not only to inhibit NOS 10 11 but also to lower NO concentrattons by the production of superoxide amon ~3 LY83583 was first reported to reduce cGMP concentrattons m the guinea pig lung by an unknown mechanism not mvolvmg a reduction of sGC activity 14 Regardless, several studies over the last decade have used it to form conclusions about the relattonshtp of NO-and sGC-associated cellular events, including vasorelaxatton m aortrc rings 8.9 An early report demonstrated that LY83583 blocked the production of endothelmm-derived relaxing factor, 15 and a very recent study has demonstrated that, like methylene blue, LY83583 also can act as an mhibnor of NOS m rat cerebellar homogenates ii The latter study," as well as othersi6.17 has revealed more parallels between methylene blue and LY83583, mcludmg the production of superoxtde anion, to explain the effects of the latter compound to decrease NOS activity or auto-oxtdize NO Therefore, it is tmpossible to use LY83583 and/or methylene blue to drfferentlate between direct mhibmon of sGC activity (te, effects on the receptor) or reductions m NOS or NO concentrations (te, effects on hgand concentrations). Garthwaite et al18 recently reported the ldentificatton of a potent, selective mhibrtor of NO-sensitive guanylyl cyclase called ODQ They demonstrated that ODQ mhrbned purified NO-stimulated sGC activity m a noncompetitive manner with respect to the substrate GTP and 3lson et al Selective Inhibitor of Guanylyl Cyclase Selected Abbreviations and Acronyms 8-bromo-cGMP = 8-bromo-guanosme 3' 5'-monophosphate ANP = type A natrnrrettc peptrde BNP = type B natrrurettc peptrde CNP = type C natnurettc pepttde GC-A, -B, -C = guanylyl cyclase-A, -B, -C LY83583 = 6-amhno-5,8-qumohnedrone NO(S) = nitric oxide (synthase) ODQ = lH-[ 1,2,4]oxadrazolo[4,3-nlqulnoxalm-lone sGC = soluble guanylyl cyclase further determined that ODQ did not inactivate reactive NO, did not produce superoxide amons, and did not block the sGC-independent effect of NO to induce macrophage cytotoxicity. 18 ODQ blocked NO-donor stimulation of sGC m intact endothehal cells and had no effect on ANP stimulation of particulate guanylyl cyclase as assessed by measurement of cGMP production by radioimmunoassay. 18 ODQ also did not inhibit forskolin-stimulated adenylyl cyclase m endothehal cells 18 Taken together, these initial results suggested that ODQ was potentially a much better reagent for assessing the involvement of sGC m NO effects than either methylene blue or LY83583
In the present study, we characterized the effects of ODQ on Mn'+-, Mn'+-GTP-, and deta nonoate 19-stimulated sGCs m the cytoplasmic fraction from COS-7 cells overexpressmg the LY~ and pi subunits of the rat enzyme (COS-7 sGC cells) Furthermore, we also examined the effect of ODQ m cells overexpressmg particulate forms of the enzyme GC-A, GC-B, and GC-C, which act as receptors for ANP, CNP, and heat-stable enterotoxm, respectively Followmg this characterization, we used ODQ m rat isolated aortic rings to test the hypothesis that sGC mediates vasorelaxant activity associated with NO donation
General

Methods
Unless specified m the followmg text, common laboratory reagents used m this study were purchased from either Sigma Chemical Co or Fisher Sctenttfic All protease mhtbttors were from Sigma Chemical Co as well unless otherwise noted Cell Culture and Transfection Cells were mamtamed m a humidified 95% an-5% CO2 waterJacketed incubator (Nuarre) at 37°C. HEK-293 cells overexpressmg stable transfectants of rat GC-A, GC-B, and GC-C (HEK-293 GC-A, -B, and -C cells, respectively) were kindly provided by Dr David L Garbers (Howard Hughes Medical Instttute, Umverstty of Texas Southwestern Medical Center [Dallas] ) and cultured as described *a 22 COS-7 cells were cultured as previously described23 and transfected with the a, and PI subunits of sGC by the DEAE/ dextran method 24 The rat (Y, and PI subunit cDNAs m the mammalian expressron vector (pCMV5) were also provided by Dr D.L Garbers 25 The expression of active sGC requires the cotransfectron of both (Y and p subunits 25-29 Cells were cotransfected with 5 pg of each subumt Mock-transfected cells were transfected with 10 pg pCMV, Cells were allowed to grow for 48 hours before experrmentatton Expression of both subunits was confirmed by deta nonoate (nonoate) (Cayman Chemtcal)-stimulated production of cGMP m whole cells or guanylyl cyclase actrvtty m soluble fractions from these cells
Rat Aortic Vascular Smooth Muscle Cells
Cells were isolated according to the method of Dtgho et al 30 Male Sprague-Dawley rats (300 to 400 g) were given a lethal mtraperttoneal mlectron of sodium pentobarbrtal(50 mg/kg), and a thoracotomy was performed to remove the full-length thoracrc aorta. These mampulatrons were performed m accordance with the Medical College of Wtsconsm Animal Care Commrttee gmdelmes Ring explants (1 to 1 5 mm thick) were placed mto 24-well tissue culture plates (Falcon) contammg Dulhecco's modified Eagle's medium (Grbco Life Technologtes) supplemented with 10% defined fetal bovine serum (Hyclone Lab) Explants were removed 3 to 4 days later, and the cells remammg on the dish were grown to confluence Growth medium was the same as that above during explantatton with the following supplements 2 mmol/L L-glutamme, 100 U/mL pemcillm, and 70 pmol/L streptomycm (Grbco) The smooth muscle identity of these cultures was verified morphologrcally (te, htll and valley growth pattern) and by tmmunohtstochemrcal stammg for both the presence of smooth muscle-specific cu-actm and the absence of factor VIII antigen Immunohrstologrcal staining verified that the cells were more than 97% smooth muscle The cells were used m passages 4 to 6 Bovine Coronary Artery Endothelial Cells Endothehal cells were kindly provided by Dr Wtlham B Campbell (Medical College of Wrsconsm [Milwaukee] ) The tsolatron and culturing condmons of these cells have been prevrously descrtbedsr and were followed throughout these studies
Whole-Cell cGMP Production Studies
Experiments testing ODQ effects (Tocrts Cookson) on parttculate guanylyl cyclases were examined m HEK-293 GC-A, -B, and -C cells overexpressmg each of these enzymes Those testing the effects of ODQ on sGC were performed m both COS-7 sGC cells and rat aorttc vascular smooth muscle cell primary cultures All experiments were performed m two patred 24-well plates (Falcon or Sarstedt) One plate received ODQ treatment and the other ODQ vehicle (ethanol) Before mmatron of experiments, confluent plates of cells were rinsed twice with 5 mL PBS (pH 7 4, 37°C). Cells were premcubated at 37°C for 10 minutes with 0 25 mmol/L rsobutylmethylxanthme and ODQ vehicle or 10 bmol!L ODQ m HEPES (25 mmoI/L)-buffered (pH 7.4) Dulbecco's modified Eagle's medium (Medical College of Wrsconsm Tissue Culture Facthty) Premcubatron medium was removed and replaced with fresh buffer of the same components with the appropriate guanylyl cyclase agonist for 5 minutes at 37°C Four paired experiments were performed per set of ODQ vehicle-and ODQ-treated plates HEK-293 GC-A, -B, and -C cells were treated with vehicle (water) and increasing concentratrons of ANP, CNP, and heat-stable enterotoxm, respectively COS-7 sGC cells and rat aortrc vascular smooth muscle cells were treated with nonoate vehicle (0 01 mol/L NaOH) and increasing concentrations of the NO donor or tts by-product, ethylamme (Aldrich Chemical Co). Spectfically, vehicle or one of five concentrattons of agonist was given per well (ANP, CNP, heat-stable enterotoxin vehicle, lo-", lo-", lo-*, 10m7, or 10d6 mol/L, nonoate/ ethylamme. vehicle, 10m6, lo-', 10e4, lo-', or lo-'mol/L) After the 5-minute mcubatton period, the supernatants were aspirated, and the guanylyl cyclase reaction was terminated by the addition of 0 5 mL of 1 mol/L perchloric acid Antiserum for cGMP was graciously supplied by Dr D L Garbers 32 Samples contammg cGMP were subJected to alumina-Dowex ton-exchange column punficatron~2 and radtormmunoassay as previously described z7 34 Resultant samples were counted on a Packard Cobra II AutoGamma Counter Guanylyl Cyclase Assay COS-7 sGC Cells Two days after transfectron, COS-7 sGC cells were harvested and resuspended m 10 mmol/L HEPES (pH 7 4) 150 mmol/L Hypertension Vol29, No 1, Part 2 January 1997 NaCl, 1 mmol/L EDTA, 1.5 bmol/L aprotmm, 10 hmol/L E-64 (Boehrmger Mannhetm Biochemicals), and 0 1 pmol/L PMSF After homogemzahon, cytosohc proteins were isolated by centrifugation (15 OOOg, 30 minutes, 4°C) Guanylyl cyclase activtty was determmed m 100~PL reactions containing 5 pg soluble protern,35 40 mmol/L triethanolamme HCl, pH 7 5, 0.25 mmol/L isobutylmethylxanthme, 2 mmol/L D'IT, 1 pmol/L PMSF, and 1 pmol/L pepstatm A In kmettc studies, 5-minute reactions were performed m the presence or absence of ODQ (10 pmol/L) at 37°C containing the varied or fixed concentrattons of Mn*', Mn*+-GTP, and/or nonoate as described m "Results" and m Table 1 The synthesis of cGMP was vertfied to be linear over the 5-mmute course of the experiment. Reactions were terminated, and cGMP was purified and quantified as described above For assays quantifying the conversion of radiolabeled GTP to cGMP, the reaction mixture also contamed 1 $1 [c?P]GTP (ICN Radiochemtcals) and either 600 nmoVL Mn2+ per 100 nmol/L GTP or 1 1 mmol/L Mn*+ per 1 mmol/L GTP Proteins were premcubated (10 mmutes, 37°C) either m the presence of 10 pmol/L ODQ or vehicle (ethanol) before the addition of Mn*+-GTP Reacttons were terminated after 5 minutes by the addition of 0 5 mL 110 mmol/L zmc acetate and 0 5 mL 110 mmol/L sodium bicarbonate Samples were centrifuged (lOOOg, 5 mmutes), and supernatants were purified over alumina columns 36 Eluates containing [32P]cGMP were subJected to scmtillation counting on Packard Instrument Tri-Carb 2 1 OOTR
Rat Aortas
Male Sprague-Dawley rats (300 to 400 g) were given a lethal mtraperttoneal inJectron of sodmm pentobarbital (50 mg/kg) These mampulahons were performed m accordance with the Medical College of Wtsconsm Animal Care Committee gmdelmes For each expertment, three full-length thoracic aortas were obtained, and the fascia was carefully removed from each vessel Aortas were homogemzed on me m 5 mL buffer containing 25 mmol/L triethanolamme HCl (pH 7 6), 10 mmol/L NaCl, 5 hmol/L aprotmm, 10 pmol/L E-64, and 0 1 pmol/L PMSF Guanylyl cyclase assays were performed m 100 PL of the above buffer containing 20 pg protein35 and 0 25 mmol/L isobutylmethylxanthme as descrtbed above for COS-7 sGC cells Samples were premcubated with ODQ vehicle or 10 pmol/L ODQ before the addttton of nonoate vehicle or 1 mmol/L nonoate to stimulate the enzyme for 5 minutes Reactions were stopped, samples punfied, and cGMP levels determined as described above NOS Activity Male Sprague-Dawley rats (300 to 400 g) received a lethal mtraperttoneal mJection of sodmm pentobarbital (50 mg/kg) These mampulattons were performed m accordance with the Medical College of Wtsconsm Animal Care gmdelmes Thoracic aortas were removed and nngs prepared m 5-mL tissue baths as previously described 33.38 Contractile responses were monitored using Grass mstrumentatton as described 3138
After the premcubation and precontractions, one rmg of each pair received ODQ vehicle (ethanol) and the other rmg received ODQ (10 pmol/L) 15 minutes before the addition of the LY,-selective adrenoceptor agonist phenylephrme (100 nmol/L) The rings were allowed to maxtmally contract over the next 15 minutes before the addttton of vehicle and increasing cumulative concentrations of nonoate (1O-8 to 3X10-' mom), ANP (lo-" to lo-' mol/L), CNP (lo-" to 10m6 mol/L), mtroglycenn (lo-' to 3X 10m6 mol/L), tsoproterenol (lo-* to lo-' mom), brmakahm (lo-" to lo-$ mol/L), 8-bromo-cGMP (lo-' to 3~ 10m4 mol/L, ICN Biochemicals), or the nonoate by-product ethylamme (IO-* to lo-" mol/L) every 4 minutes or until a plateau was reached followmg each addition of relaxant agomst Because nonoate must be stored m 0 01 mol/L NaOH to avoid hydrolysis, appropriate dtlutions of the NO donor m Krebs' buffer were made approximately 1 minute before addition to the tissue baths to ehmmate the potential for aikalmrzatton of the bathing medium and associated nonspecific effects Nitroglycerm was manufactured by Parke-Davis, and btmakahm was manufactured by Merck KGaA Co39 and graciously provided by Dr Garrett J Gross (Medical College of Wisconsm [Milwaukee] ) 40
In the presence of paired ODQ vehicle-and ODQ-treated aortic rmgs, we also tested not only for potenttal desensttization to phenylephrme-induced contractions over time but also for possible time-dependent nonoate-vehicle effects on contractile activity Two sets of paired rings were contracted with phenylephrme with or without nonoate-vehicle treatment (ie, appropriate ddutions of the nonoate storage solutton, 0 01 mol/L NaOH, akm to those above for nonoate treatment) over a 65-mmute penod every 4 to 8 minutes to approximate the time necessary for complete responsiveness to each nonoate addition durmg typical expenmentation Nonoate (1 mmol/L) was added to the paired vessels after the completion of these time-dependent experiments to verify the capacity of each rmg to respond to the NO donor Auto-oxidation of NO NO measurements were performed using a commercially available Clark-type electrode &o-NO, World Precision Instruments) and documented on a strip-chart recorder The electrode was calibrated daily using actdtfied potassium mtnte as the NO donor accordmg to the manufacturer's mstructrons All measurements were made under constant stnrmg The effects of ODQ or the superoxide generating system xanthme/xanthme oxtdase were studied using a small plastic vial containing 2 mL Krebs' bicar- bonate buffer (pH 7 4)x8 and 2x10' COS-7 cells or a rat aorttc ring The electrode was allowed to equlhbrate after which nonoate (50 pmol/L) was added After the electrode signal restabtltzed m the presence of nonoate, ODQ (10 pmol/L), xanthme (10 ,umol/L), xanthme oxldase (5 U/mL), or a combmatlon of xanthme (10 pmol/L) and xanthme oxtdase (5 U/mL) were added, and changes m NO concentration were recorded
Data Analyses
The effect of ODQ on agonist-stimulated cGMP productton m whole cells and agomst-or &bromo-cGMP-induced relaxation of precontracted rat aorttc rings was assessed by comparison of control (agonist vehicle) to each treatment concentration by Dunnett's modtficatton of Student's paired I test The effect of ODQ over the full concentratton-response curve was assessed for each agomst or 8-bromo-cGMP by repeated measures ANOVA K,,, and V,,, values from the kinetic assays of enzyme activity from the cytoplasmtc fraction of COS-7 sGC cells were determined by tradtttonal double-reciprocal conversions 41 Stattsttcal compartsons between ODQ-treated and ODQ vehicle-treated preparations for both K,,, and V,,,, values were made using Student's paired t test
In all figures and tables, astensks denote the statisttcal slgnificance (*P< 05, **P< 01, ***P< 001) of a specific treatment when compared with a matched control group (te, vehicle treatment)
Results
Effect of ODQ on NO-Donor-Mediated Stimulation of cGMP Production
These experiments were destgned to compare the effects on nonoate-mediated cGMP productton m both rat aorttc vascular smooth muscle cells (Fig 1 A) and COS-7 sGC cells (Fig IB) In both rat aortic vascular smooth muscle cells (Fig IA) and COS-7 sGC cells (Fig lB) , nonoate (10T5 to 10m3 mol/L) resulted m a concentratton-dependent (ANOVA P<.OOOl) increase in cGMP production with an EC50 value of approximately 30 pmol/L. In aorttc cells (Frg lA), no greater effect was obtained after 10 mmol/L nonoate treatment (n=2, L.J.O., T C.H., J.G.D., unpublished data, 1996), similar to the results in COS-7 sGC cells (Fig 1B) Therefore, m both cell types, 1 mmol/L nonoate resulted m a maximal effect on cGMP production We chose to use a loPmollL concentratton of ODQ in these studies on the basis of previous results demonstrating that concentration to be maxtmally effective. 18 Pretreatment with ODQ reduced the abrlrty of nonoate to mcrease cGMP levels in COS-7 cells (Fig 1B) and completely blocked the nonoate effect m the vascular smooth muscle cells (Fig 1A) (both by ANOVA, P< 0001) We also found that ODQ completely prevented maximal nonoate (1 mmol/L) stimulation of guanylyl cyclase activity in soluble fractions from rat thoracrc aorta, consistent with the results in aortrc smooth muscle cell cultures (L.J.0 , J.G. D., unpublished data, 1996) .
Nonoate 1s known to hydrolyze mto equal molar amounts of NO and ethylamme at neutral PH. rg As a control for a byproduct effect, ethylamme (10e7 to 10e3 mol/L) was tested for any effect on sGC acttvtty. It was found to be without effect (L-J 0, J.G.D., unpublished data, 1996).
Effect of ODQ on Nonoate-and NitroglycerinMediated Relaxation of PhenylephrinePrecontracted Rat Aortas
These experiments were performed to determme whether ODQ blocked the vasorelaxant activity of two NO donors, nonoate and mtroglycerm. The summary data from several experiments assessmg the effect of ODQ on nonoate-mduced relaxation are shown m Fig 2. In the absence of ODQ pretreatment, nonoate ( 10e7 to 10e4 mol/L) resulted in a concentratton-dependent relaxation of phenylephrmeprecontracted rat aorta (I&,= 1 pmol/L, ANOVA, P< 0001) Complete relaxation was observed on reaching a final nonoate concentration of 10e4 mol/L in the absence of ODQ. After ODQ (10 pmol/L) treatment, the IC50 for nonoate (ANOVA, P< 0001) was increased by 30-fold, and the maximal effect of nonoate was attained at lo-' mol/L and reduced by about 75%. No further relaxation ---*-- Vol29, No 1, Part 2 January 1997 was observed at 3~10~~ mol/L nonoate (n=3) These results are consistent with a mixed competittve/noncompetittve antagonism of NO effects in the rat aorta. The same ODQ concentration also blocked the ability of mtroglycerm to relax phenylephrme-precontracted aorta in a similar manner (n=3, unpublished data, 1996) . Neither the nonoate by-product,'9 ethylamme (lo-' to 10m3 mol/L), nor the nonoate vehicle (ethanol) had any effect on basal-or phenylephrme-induced rat aortic contractions (L.J O., J.G.D , unpublished data, 1996; Ftg 2)
The nonoate-mediated relaxation in the ODQ-treated vessel also was not simply due to time-dependent loss of contractile acttvtty, nonoate-vehicle effect, or desensitization to phenylephrme. Control experiments were performed whereby phenylephrme was added to paired ODQ-treated and ODQ vehicle-treated aortic rings The associated phenylephrme-induced contractions were maintained with or without nonoate-vehicle treatment for the approximate 65-minute duration of the experiments m these studies (n=3). In both variations, addition of 1 mmol/L nonoate at the end of this time period resulted in complete relaxation of the ODQ vehicle-treated ring and partial relaxation (=20% to 25%) of the ODQ-treated vessel (n=3), akm to the results of Ftg 2
Effect of ODQ on sGC Activity in the Cytosolic Fraction From COS-7 sGC Cells
It has been prevtously shown that maximal rat lung sGC acttvation is obtained in the presence of excess Mn2+ over GTP 42 For kmetic analysis of an enzyme system requiring an excess concentration of cation over nucleottde, the system can be viewed as having two substrates. a metalnucleottde chelate, Mn'+-GTP, and the metal ion, Mn2+ 43 Chnsman et a142 have prevtously demonstrated that sGC is such an enzyme. Similar methods to those of the latter study42 were used m the followmg experiments assessing enzyme activation in the cytoplasmic fraction from COS-7 sGC cells These studies were performed to determine whether ODQ was a competitive and/or noncompetitive mhibitor of sGC with respect to NO, Mn2+, and Mn"'-GTP K,,, and V,,, values of sGC for Mnzf and Mnzf-GTP were determined at near-saturating concentrattons42 of Mn'+-GTP (2 mmol/L) and Mn*+ (125 ymol/L), respectively, in the presence and absence of ODQ (Table 1) In both variations, ODQ had a stattstically stgmficant effect to lower V,,, approximately threefold with no effect on K,,, (Table 1) The NOS mhtbttor, N"'-mtro-L-argmme (0 1 mmol/L) did not alter these kinetic reactions (L J 0 , J G D , unpublished data, 1996) . These results indicate a noncompetttive mhibttion with respect to both metal-nucleotide chelate or Mn2+ independent of the presence of NO. Km and V,,, values of sGC for NO were determined m the presence and absence of ODQ with fixed concentrations of Mn2+ (125 pmol/L) and GTP (12 5 pmollL)44 (Table 1 ) As shown in Table 1 , ODQ significantly lowered the V,,, and increased the K,,, (approxtmately twofold) of the enzyme for nonoate-donated NO. The latter result argues that ODQ is a mixed competittve/noncompetitive inhibitor with respect to NO donation. In all three variations, the synthesis of cGMP was linear over the 5-minute course of the experiment. Subsequent expenments also demonstrated that NOS activity was not detected m COS-7 sGC cells (see below, Table 2 ). The purpose of these experiments was to test for an effect of ODQ on NOS acttvity m endothehal cells and m COS-7 sGC cells Table 2 shows that NW-mtro+argmme and methylene blue (0 1 mmol/L each) completely block the conversion of [ 3H]-L-argmme to [ 3H]-L-cttrullme m bovine coronary artery endothehal cells. ODQ (10 pmol/L), however, does not effect the same reaction, demonstrating that it does not modulate NO generation NOS activity was not detectable m COS-7 sGC cells (Table 2) Effect of Xanthine/Xanthine Oxidase and ODQ on the Auto-oxidation of Nonoate-Donated NO These studies determmed whether ODQ could oxidize NO m the presence of COS-7 cells or rat aortic rmgs at physiological pH In both of these preparations, the effects of the superoxtde generating system xanthmelxanthme oxidase and ODQ were examined Followmg treatment with 50 ,umol/L nonoate m the presence of xanthmelxanthme oxidase vehicle, the concentration of NO generated was 168215 nmol/L (n=3) or 266+47 nmol/L (n=2) m the presence of COS-7 cells or aorta, respechvely Combined treatment with xanthme (10 pmol/L) and xanthme oxidase (5 U/mL) lowered the levels of nonoate-donated NO from those obtained m the presence of nonoate and xanthme/xanthine oxidase vehicle (above) to 49.4?9.8% for COS-7 cells (n=3) and 22 123 2% (n=2) for aortic rings In contrast, ODQ (10 pmol/L) did not result m reductions of NO concentrations, which were 105 l+l 3% (n=3) and 107 820 2% (n=2) of the control levels reached m the presence of both 50 pmol/L nonoate and xanthme/xanthme oxidase vehicle (above) for COS-7 cells and rat aortic rmgs, respectively Xanthme (10 pmol/L) or xanthme oxidase (5 U/mL) alone had no effect on the amount of nonoate-donated NO m the presence of COS-7 cells or aorttc rmgs (L J.O., E T.K., J G D , unpublished data, 1996) Lack of ANP-, CNP-, and Heat-Stable EnterotoxinStimulated cGMP Production in HEK-293 Cells Expressing Stable Transfectants of GC-A, -B, and 4, Respectively These experiments were designed to test whether ODQ had any effect on the membrane-associated guanylyl cyclases GC-A, -B, or -C ANP, CNP, and heat-stable enterotoxm (10-l' to lo+ mol/L) result in concentrationdependent (ANOVA, P<.OOOl) sttmulation of cGMP production m HEK-293 GC-A (Fig 3A) , -B (Fig 3B) , and -C (Fig 3C) cells, respectively. ODQ pretreatment had no To further examine the specifictty of ODQ for blocking NO-mediated vasorelaxation, we also tested the quinoxalm derivative for any antagomsttc effect on two other known vasodilatory agents that signal their cellular responses independent of guanylyl cyclase activatron ODQ (10 pmol/L) was found to have no effect on the vasorelaxation facilitated by the ,&selective adrenoceptor agonist isoproterenol45 and the ATP-sensitive Kt channel opener brmakalim39240 (L.J. O., J G D , unpublished data, 1996) .
Discussion
Nonoate resulted m a concentration-dependent stimulation of cGMP production m rat aortlc vascular smooth muscle cells and COS-7 sGC cells The ability of nonoate to increase cGMP synthesis m these cells was sigmficantly attenuated by ODQ pretreatment, consistent with a potential mhibrtory effect of the qumoxalm-derivative on sGC 18 More specifically, ODQ completely blocked nonoate effects m the aortic cells and slgmficantly shifted the nonoate concentration-response curve m the COS-7 sGC cells to the right and suppressed the maximal effect. ODQ therefore presented a mixed competltlve/noncompetitlve antagonism. Nonoate and nitroglycerin, another NO donor, were likewise found to relax phenylephrme-precontracted rat aorta m a concentration-dependent manner ODQ caused a sm-ular significant nghtward shift of the nonoate-response curve and an attenuation of the maxlmal effect, mdlcatmg a competitlve/noncompetltive mhlbltlon of the vasorelaxant effect of the NO donor This result 1s consistent with the observations on whole-cell cGMP productlon m this study and a previous study m isolated intact bovine pulmonary arteries 46 These data led to a further charactenzatlon of ODQ effects on the NO/sGC/cGMP slgnalmg cascade in both the COS-7 sGC cells and rat aortas. ODQ could have resulted m the observed effects on cGMP concentrations by dlrectly mhlbltmg sGC or lowenng donated-NO concentratlons by the generation of superoxide amon Kmetlc studies on sGC activity m the cytosollc fraction from COS-7 sGC cells demonstrated that ODQ is a mixed competitive/noncompetitive inhibitor of the enzyme with respect to nonoate stimulation m the presence of fixed concentrations of Mn2+ and Mn2+-GTP This result 1s consistent with the pharmacological activity of ODQ on both nonoate-mediated cGMP production m whole cells and aortic vasorelaxation and with a recent report that ODQ acts m part by binding to the heme-moiety 46 Additionally, we considered whether the noncompetitive effect of ODQ on sGC activity was mediated by competition with metal ion-or nucleotide-substrate Kinetic studies with a saturating concentration of Mn2'-GTP or Mn*+ revealed that ODQ was a noncompetitive mhibltor with respect to varying concentrations of Mn2+ or Mn'+-GTP, respectively, m the absence of NO donatlon or NOS activity Taken together, our kmetlc data suggest that ODQ can modulate enzyme activity both by effects on the NO bmchng site and by interacting with a region other than that associated with NO, metal, or nucleotlde bmdmg 47
The results of the present study with ODQ also yield a clearer conclusion than those previously associatmg sGC with vasorelaxation using LY83583 and/or methylene blue For over the last decade, both compounds have been touted as sGC inhibitors They are now known to be nonspecific m then mhibltory effects on the NO/cGMP signal transduction pathway, mcludmg the machvation of reactive NO~2J6J7 and the mtibition of endothehum-derived relaxmg factor generation' or NOS activity in the present study, as well as others 10~1 Moreover, LY83583 also may reduce cGMP levels m cells by an unknown mechamsm not associated with reductions of sGC activity I4 We found that ODQ does not m&bit NOS activity and does not auto-oxi&ze NO m the presence of COS-7 cells or aortic rmgs. The latter result 1s consistent with the previous report demonstrating that ODQ does not oxldlze NO m the absence of cells and does not attenuate NO-mediated macrophage toxlclty 18
The effects of ODQ on vasorelaxation and cGMP production are also selective for NO. ODQ chd not affect ANPand CNP-induced aortlc vasorelaxatlon or ANP-, CNP-, and heat-stable enterotoxm-stimulated cGMP production m HEK-293 GC-A, -B, and -C cells, respectively GC-A, GC-B, and the related heat-stable enterotoxm receptor GC-C would all be potential targets for ODQ, since they are highly conserved m the catalytic region in comparison to sGC 1 In the present study, ODQ also did not attenuate the relaxation evoked by either lsoproterenol, a P-selective adrenoceptor agonist,45 or bimakahm, an ATP-sensitive K+ channel opener 39.40 The former 1s thought to relax vascular smooth muscle by increasing adenylyl cyclase actlvlty45 and the latter by hyperpolmzatlon resembling that of endothehum-derived hyperpolarlzmg factor 3~4~~48 ODQ also does not have any apparent effect on vascular activity of cGMP downstream of cyclase activauon (le, protein kmase or phosphochesterase stimulation) This conclusion 1s based on the novel observations that ODQ IS unable to block membrane-permeable cGMP analogand CNP-mediated vasorelaxatlon m the absence of the phosphodlesterase mhlbitor, lsobutylmethylxanthme. A vasorelaxant role for GC-B has been previously established m that a monoclonal antibody specific to the extracellular region of GC-B blocks CNP bmdmg, CNP-medlated production of cGMP, and CNP-induced relaxation of phenylephrme-contracted rat aorta 33
Interestingly, ODQ does not fully antagonize nonoatemediated aortic relaxation but completely ablates the NOdonor-stimulated cGMP production even at maximally efficacious concentrations (ie, 1 mmol/L) in rat aortic vascular smooth muscle cells and m soluble protem fractions from rat aorta, respectively Similar results usmg ODQ m bovine pulmonary artenes led to the suggestlon of sGC-dependent and sGC-independent mechanisms for NO-mediated vascular relaxation 46 The data from the present study could be interpreted to fit this dichotomy as well. However, perhaps the assay of NO-donor effects on vascular smooth muscle reactivity 1s more sensltlve than the current measurements of intracellular cGMP concentrations, rendering a clear conclusion of two separate pathways impossible at this time Future studies may be able to address this issue more Judiciously with comparisons of NO-donor activity m isolated vessels from wild-type versus sGC-gene knockout animals, if and when the latter become available
The results of the present study clearly demonstrate that ODQ can inhibit sGC activation independent of the presence of NO donors or NOS activity and that ODQ neither modulates the vascular effects of membrane permeable cGMP analogs nor auto-oxidizes NO. These observations chssoelate the activities of ODQ from effects on NO concentrations and downstream cGMP-mechated cellular events (eg, activation of cyclic nucleotlde-sensitive protem kmases or cyclic nucleotide-mediated activation of ion channels), further supportmg a &rect effect of the qumoxahn denvatlve to inhibit the purified enzyme l8.47 These data support the hypothesis that sGC mediates vasorelaxant actlvlty associated with NO donors ODQ ~111 likely become an lmportant tool m attempting to differentiate between sGCdependent and -Independent effects of NO
